Medicalsystem Biotechnology Co., Ltd. (300439.SZ)
CNY 11.02
(-1.34%)
CNY 11.02
(-1.34%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 23.59 Million CNY | -30.62% |
| 2022 | 34 Million CNY | -51.87% |
| 2021 | 70.66 Million CNY | -27.16% |
| 2020 | 97.02 Million CNY | -60.08% |
| 2019 | 243.01 Million CNY | 102.51% |
| 2018 | 120 Million CNY | 561.16% |
| 2017 | 18.15 Million CNY | -82.55% |
| 2016 | 104 Million CNY | 0.0% |
| 2015 | - CNY | 0.0% |
| 2014 | - CNY | 0.0% |
| 2013 | - CNY | 0.0% |
| 2012 | - CNY | 0.0% |
| 2011 | - CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 19.69 Million CNY | 0.0% |
| 2024 Q3 | 24.59 Million CNY | 0.0% |
| 2024 Q2 | 17.69 Million CNY | 0.0% |
| 2023 Q3 | 19.82 Million CNY | -9.13% |
| 2023 FY | 23.59 Million CNY | -30.62% |
| 2023 Q1 | 31.41 Million CNY | -7.61% |
| 2023 Q2 | 21.81 Million CNY | -30.56% |
| 2023 Q4 | 23.59 Million CNY | 19.02% |
| 2022 Q4 | 34 Million CNY | 36.05% |
| 2022 FY | 34 Million CNY | -51.87% |
| 2022 Q2 | 24.74 Million CNY | -63.3% |
| 2022 Q1 | 67.43 Million CNY | -4.57% |
| 2022 Q3 | 24.99 Million CNY | 1.01% |
| 2021 Q3 | 74.11 Million CNY | 0.0% |
| 2021 Q2 | 74.1 Million CNY | -37.96% |
| 2021 Q1 | 119.44 Million CNY | 23.12% |
| 2021 FY | 70.66 Million CNY | -27.16% |
| 2021 Q4 | 70.66 Million CNY | -4.64% |
| 2020 FY | 97.02 Million CNY | -60.08% |
| 2020 Q4 | 97.02 Million CNY | -10.6% |
| 2020 Q3 | 108.52 Million CNY | -29.31% |
| 2020 Q2 | 153.52 Million CNY | -18.78% |
| 2020 Q1 | 189.01 Million CNY | -22.22% |
| 2019 Q2 | 282 Million CNY | 120.31% |
| 2019 Q1 | 128 Million CNY | 6.67% |
| 2019 FY | 243.01 Million CNY | 102.51% |
| 2019 Q4 | 243.01 Million CNY | -8.99% |
| 2019 Q3 | 267 Million CNY | -5.32% |
| 2018 Q2 | 30 Million CNY | 2999999888.82% |
| 2018 Q1 | 1.00 CNY | -100.0% |
| 2018 FY | 120 Million CNY | 561.16% |
| 2018 Q4 | 120 Million CNY | -9.56% |
| 2018 Q3 | 132.68 Million CNY | 342.27% |
| 2017 FY | 18.15 Million CNY | -82.55% |
| 2017 Q1 | - CNY | -100.0% |
| 2017 Q4 | 18.15 Million CNY | 0.0% |
| 2017 Q3 | - CNY | 0.0% |
| 2017 Q2 | - CNY | 0.0% |
| 2016 Q2 | 1.00 CNY | -0.0% |
| 2016 Q4 | 104 Million CNY | 10399999900.0% |
| 2016 Q3 | 1.00 CNY | 0.0% |
| 2016 Q1 | 1.00 CNY | 0.0% |
| 2016 FY | 104 Million CNY | 0.0% |
| 2015 Q2 | - CNY | 0.0% |
| 2015 Q3 | - CNY | 0.0% |
| 2015 Q1 | - CNY | 0.0% |
| 2015 FY | - CNY | 0.0% |
| 2015 Q4 | - CNY | 0.0% |
| 2014 Q4 | - CNY | 0.0% |
| 2014 Q1 | - CNY | 0.0% |
| 2014 FY | - CNY | 0.0% |
| 2014 Q3 | - CNY | 0.0% |
| 2013 FY | - CNY | 0.0% |
| 2012 FY | - CNY | 0.0% |
| 2011 FY | - CNY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Dian Diagnostics Group Co.,Ltd. | 2.33 Billion CNY | 98.987% |
| Hangzhou Tigermed Consulting Co., Ltd. | 434.22 Million CNY | 94.566% |
| Dirui Industrial Co.,Ltd. | 3.66 Million CNY | -543.467% |
| Beijing Strong Biotechnologies, Inc. | 1.13 Billion CNY | 97.915% |
| Maccura Biotechnology Co.Ltd | 175.47 Million CNY | 86.553% |
| Guangzhou Wondfo Biotech Co.,Ltd | 580.52 Million CNY | 95.935% |
| Guangdong Hybribio Biotech Co.,Ltd. | 28.26 Million CNY | 16.529% |
| BGI Genomics Co., Ltd. | 283.42 Million CNY | 91.675% |
| Amoy Diagnostics Co., Ltd. | 44.4 Million CNY | 46.856% |
| Shanghai Labway Clinical Laboratory Co., Ltd. | 166.83 Million CNY | 85.857% |